UMediC Group Berhad - Asset Resilience Ratio
UMediC Group Berhad (0256) has an Asset Resilience Ratio of 1.48% as of October 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read UMediC Group Berhad total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how UMediC Group Berhad's Asset Resilience Ratio has changed over time. See shareholders equity of UMediC Group Berhad for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down UMediC Group Berhad's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 0256 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 0% |
| Short-term Investments | RM1.41 Million | 1.48% |
| Total Liquid Assets | RM1.41 Million | 1.48% |
Asset Resilience Insights
- Limited Liquidity: UMediC Group Berhad maintains only 1.48% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
UMediC Group Berhad Industry Peers by Asset Resilience Ratio
Compare UMediC Group Berhad's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 50.79% |
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
Annual Asset Resilience Ratio for UMediC Group Berhad (2022–2025)
The table below shows the annual Asset Resilience Ratio data for UMediC Group Berhad.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-07-31 | 5.43% | RM4.95 Million ≈ $1.24 Million |
RM91.22 Million ≈ $22.90 Million |
-5.79pp |
| 2024-07-31 | 11.22% | RM9.28 Million ≈ $2.33 Million |
RM82.71 Million ≈ $20.77 Million |
-4.98pp |
| 2023-07-31 | 16.20% | RM11.87 Million ≈ $2.98 Million |
RM73.29 Million ≈ $18.40 Million |
-14.29pp |
| 2022-07-31 | 30.49% | RM21.01 Million ≈ $5.27 Million |
RM68.89 Million ≈ $17.30 Million |
-- |
About UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more